Suchergebnisse - "Organoplatinum Compounds/therapeutic use"

Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07

Autoren: Seung Tae Kim Sun Young Kim Jeeyun Lee et al.

Weitere Verfasser: Seung Tae Kim Sun Young Kim Jeeyun Lee et al.

Quelle: J Clin Oncol

Schlagwörter: Organoplatinum Compounds, Leucovorin, Fluorouracil / therapeutic use, Colonic Neoplasms* / pathology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms* / drug therapy, Chemotherapy, Humans, Adjuvant, Capecitabine, Neoplasm Staging, Leucovorin / therapeutic use, Organoplatinum Compounds* / therapeutic use, ORIGINAL REPORTS, Oxaliplatin* / therapeutic use, 3. Good health, Oxaliplatin, Capecitabine / therapeutic use, Chemotherapy, Adjuvant, Colonic Neoplasms, Fluorouracil

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35772045

Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Autoren: Keunchil Park Eric B. Haura Natasha B. Leighl et al.

Weitere Verfasser: Keunchil Park Eric B. Haura Natasha B. Leighl et al.

Quelle: J Clin Oncol
Park, K, Haura, E, Leighl, N B, Mitchell, P, Shu, C, Girard, N, Viteri, S, Han, J-Y, Kim, S-W, Lee, C K, Sabari, J, Spira, A, Yang, T-Y, Kim, D-W, Lee, K H, Sandborn, R, Trigo, J, Goto, K, Lee, J-S, Yang, J C-H, Govindan, R, Bauml, J M, Garrido, P, Krebs, M, Reckamp, K, Xie, J, Curtin, J, Haddish-Berhane, N, Roshak, A, Millington, D, Lorenzini, P, Thayu, M, Knoblauch, R & Cho, B C 2021, 'Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study', Journal of Clinical Oncology. https://doi.org/10.1200/JCO.21.00662

Schlagwörter: Male, Lung Neoplasms, Organoplatinum Compounds, Nsclc, Bispecific antibody, Immunological / administration & dosage, Trial, Immunological / pharmacokinetics, Hypokalemia / chemically induced, Antineoplastic Agents, Immunological, 0302 clinical medicine, Jnj-61186372, Carcinoma, Non-Small-Cell Lung, Antibodies, Bispecific, 80 and over, Paronychia, Neutropenia / chemically induced, Aged, 80 and over, Manchester Cancer Research Centre, Drug Eruptions / etiology, Immunological / adverse effects, Gefitinib, ORIGINAL REPORTS, Exons, Middle Aged, Pulmonary Embolism / chemically induced, Progression-Free Survival, 3. Good health, Cmet, ErbB Receptors, Organoplatinum Compounds / therapeutic use, Retreatment, Disease Progression, Female, Drug Eruptions, Paronychia / chemically induced, Adult, Diarrhea, Injection Site Reaction / etiology, Neutropenia, Lung Neoplasms / pathology, Lung Neoplasms / drug therapy, Antineoplastic Agents, Hypokalemia, Outcomes, Antibodies, ErbB Receptors / genetics, 03 medical and health sciences, Bispecific / administration & dosage, Growth-factor receptor, Insertional, Humans, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / drug therapy, Aged, Lung Neoplasms / genetics, Bispecific / adverse effects, Gene-mutations, Carcinoma, Diarrhea / chemically induced, Bispecific / pharmacokinetics, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, Injection Site Reaction, Mutagenesis, Insertional, Mutagenesis, Non-Small-Cell Lung / secondary, Pulmonary Embolism

Dateibeschreibung: application/pdf

Zugangs-URL: https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.00662
https://pubmed.ncbi.nlm.nih.gov/34339292
https://research.manchester.ac.uk/en/publications/a26d5e74-f5cf-4ce7-868f-ee0aafca686b
https://doi.org/10.1200/JCO.21.00662
https://www.research.manchester.ac.uk/portal/files/204212381/jco.21.00662.pdf
https://ascopubs.org/doi/full/10.1200/JCO.21.00662
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.00662
https://www.ncbi.nlm.nih.gov/pubmed/34339292
https://www.research.manchester.ac.uk/portal/en/publications/amivantamab-in-egfr-exon-20-insertionmutated-nonsmallcell-lung-cancer-progressing-on-platinum-chemotherapy-initial-results-from-the-chrysalis-phase-i-study(a26d5e74-f5cf-4ce7-868f-ee0aafca686b).html
https://digitalcommons.psjhealth.org/publications/5132/
https://hdl.handle.net/10668/27015
https://hdl.handle.net/10668/27014
https://research.manchester.ac.uk/en/publications/a26d5e74-f5cf-4ce7-868f-ee0aafca686b
https://doi.org/10.1200/JCO.21.00662
https://pure.manchester.ac.uk/ws/files/204212381/jco.21.00662.pdf

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

Autoren: Carmela Pisano Laurence Gladieff Eric Pujade-Lauraine et al.

Weitere Verfasser: Carmela Pisano Laurence Gladieff Eric Pujade-Lauraine et al.

Quelle: European Journal of Cancer. 139:59-67

Schlagwörter: Piperazines / therapeutic use, Organoplatinum Compounds, Fanconi Anemia Complementation Group Proteins / genetics, BRCA mutation, CA-125, CT, Olaparib, Ovarian cancer, Poly(ADP-Ribose) polymerase inhibitors, Response evaluation criteria in solid tumours, Piperazines, Tumor / metabolism, 0302 clinical medicine, Germ-Line Mutation / genetics, Ovarian Neoplasms / genetics, Phthalazines / therapeutic use, Ovarian Neoplasms / drug therapy, Ovarian Neoplasms, Local / metabolism, Middle Aged, Fanconi Anemia Complementation Group Proteins, 3. Good health, Organoplatinum Compounds / therapeutic use, Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use, Disease Progression, Female, Antineoplastic Agents, Antineoplastic Agents / therapeutic use, Poly(ADP-ribose) Polymerase Inhibitors, Maintenance Chemotherapy, Local / drug therapy, 03 medical and health sciences, Biomarkers, Tumor, Humans, Germ-Line Mutation, Response Evaluation Criteria in Solid Tumors, Local / genetics, Local / pathology, CA-125 Antigen / metabolism, Ovarian Neoplasms / metabolism, Ovarian Neoplasms / pathology, Neoplasm Recurrence, CA-125 Antigen, Phthalazines, Maintenance Chemotherapy / methods, Neoplasm Recurrence, Local, Biomarkers

Zugangs-URL: https://discovery.ucl.ac.uk/10111354/3/Ledermann_Concordance%20between%20CA-125%20and%20RECIST%20progression%20in%20patients%20with%20germline%20BRCA-mutated%20platinum-sensitive%20relapsed%20ovarian%20cancer_AAM.pdf
https://pubmed.ncbi.nlm.nih.gov/32977221
https://europepmc.org/article/MED/32977221
https://www.sciencedirect.com/science/article/pii/S095980492030472X
https://pubmed.ncbi.nlm.nih.gov/32977221/
https://snucm.elsevierpure.com/en/publications/concordance-between-ca-125-and-recist-progression-in-patients-wit
https://www.ncbi.nlm.nih.gov/pubmed/32977221
https://moh-it.pure.elsevier.com/en/publications/concordance-between-ca-125-and-recist-progression-in-patients-wit-2
https://discovery-pp.ucl.ac.uk/id/eprint/10111354/

Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer.

Autoren: Fokkema, E. Groen, H.J. Bauer, J. et al.

Schlagwörter: Aged, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Carcinoma, Small Cell/blood, Small Cell/drug therapy, Female, Humans, Lung Neoplasms/blood, Lung Neoplasms/drug therapy, Male, Middle Aged, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/therapeutic use, Platinum/blood, Treatment Outcome

Relation: Journal of Clinical Oncology; https://iris.unil.ch/handle/iris/45107; serval:BIB_13228; 000084043300016

Verfügbarkeit: https://iris.unil.ch/handle/iris/45107

A retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapy.

Autoren: León, X. Hitt, R. Constenla, M. et al.

Schlagwörter: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Squamous Cell/drug therapy, Squamous Cell/secondary, Female, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/pathology, Humans, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy, Neoplasm Staging, Organoplatinum Compounds/therapeutic use, Retrospective Studies, Salvage Therapy, Survival Rate, Treatment Outcome

Relation: Clinical Oncology; https://iris.unil.ch/handle/iris/33180; serval:BIB_0413829B2C88; 000231463100003

Verfügbarkeit: https://iris.unil.ch/handle/iris/33180
https://doi.org/10.1016/j.clon.2005.02.014

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature.

Autoren: Giannone, G. Scotto, G. Katsaros, D. et al.

Schlagwörter: BRCA1 Protein/genetics, BRCA2 Protein/genetics, Drug Hypersensitivity/genetics, Female, Genes, BRCA1, BRCA2, Germ-Line Mutation, Humans, Multicenter Studies as Topic, Observational Studies as Topic, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/therapeutic use, Retrospective Studies, BRCA, Hypersensitivity reactions, Ovarian cancer, Platinum salts

Relation: Gynecologic oncology; https://iris.unil.ch/handle/iris/228823; serval:BIB_BD3BE28C9923; 000664094500013

Verfügbarkeit: https://iris.unil.ch/handle/iris/228823
https://doi.org/10.1016/j.ygyno.2021.04.018

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data

Autoren: Gabrielle Jongeneel Thomas Klausch Felice N. van Erning et al.

Weitere Verfasser: Gabrielle Jongeneel Thomas Klausch Felice N. van Erning et al.

Quelle: Int J Cancer
Jongeneel, G, Klausch, T, van Erning, F N, Vink, G R, Koopman, M, Punt, C J A, Greuter, M J E & Coupé, V M H 2020, 'Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data', International Journal of Cancer, vol. 146, no. 11, pp. 2968-2978. https://doi.org/10.1002/ijc.32629

Schlagwörter: Male, Cancer Research, treatment effect, Organoplatinum Compounds, Leucovorin, Fluorouracil/therapeutic use, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Colonic Neoplasms/drug therapy, Organoplatinum Compounds/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Journal Article, Humans, Comparative Study, Neoplasm Staging, Netherlands, Randomized Controlled Trials as Topic, Leucovorin/therapeutic use, real-world data, Research Support, Non-U.S. Gov't, randomized clinical trial, 3. Good health, adjuvant chemotherapy, colon cancer, Oncology, Chemotherapy, Adjuvant, Colonic Neoplasms, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Cancer Epidemiology, Chemotherapy, Adjuvant/methods

Dateibeschreibung: application/pdf

Zugangs-URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.32629
https://pubmed.ncbi.nlm.nih.gov/31424568
https://europepmc.org/abstract/MED/31424568
https://www.narcis.nl/publication/RecordID/oai%3Apure.atira.dk%3Apublications%2F1a7dcc03-5942-42d8-8f7c-9dcfb6f2071f
https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32629
https://www.ncbi.nlm.nih.gov/pubmed/31424568
https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.32629
https://research.vumc.nl/en/publications/estimating-adjuvant-treatment-effects-in-stage-ii-colon-cancer-co
https://research.vumc.nl/en/publications/1a7dcc03-5942-42d8-8f7c-9dcfb6f2071f
https://dspace.library.uu.nl/handle/1874/441785
https://pure.amsterdamumc.nl/en/publications/165b2c6c-92a5-495b-9c48-1858a2358c11
https://doi.org/10.1002/ijc.32629

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

Autoren: Emile, Jean François Julié, Catherine Le Malicot, Karine et al.

Quelle: the PETACC8 Study Investigators 2017, ' Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX ', European Journal of Cancer, vol. 82, pp. 16-24 . https://doi.org/10.1016/j.ejca.2017.04.025

Schlagwörter: Adult, Male, Organoplatinum Compounds, Medizin, Leucovorin, Fluorouracil/therapeutic use, Prospective cohort study, Biomarker, Colorectal carcinoma, Immune response, Biomarkers, Tumor/analysis, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Organoplatinum Compounds/therapeutic use, colorectal carcinoma, Predictive Value of Tests, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, Tumor/analysis, Prospective cohort study, Tumor-Infiltrating, Lymphocytes, Prospective Studies, Aged, Leucovorin/therapeutic use, Middle Aged, Prognosis, Survival Analysis, 3. Good health, Colonic Neoplasms, Multivariate Analysis, Oncology, Cancer Research, Colonic Neoplasms/diagnosis, Lymphocytes/pathology, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/28651158
https://hal-univ-tlse3-archives-ouvertes-fr.ezproxy.u-pec.fr/hal-01579009v1
https://www.sciencedirect.com/science/article/pii/S0959804917309528
https://hal.archives-ouvertes.fr/hal-01579009
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/260465/Details
http://www.sciencedirect.com/science/article/pii/S0959804917309528
https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01579009
https://www.sciencedirect.com/science/article/pii/S0959804917309528?via=ihub
https://doi.org/10.1016/j.ejca.2017.04.025
https://hdl.handle.net/10281/260499
https://portal.findresearcher.sdu.dk/da/publications/b6ba4204-b605-499a-a996-7030914bc87f
https://doi.org/10.1016/j.ejca.2017.04.025
https://portal.findresearcher.sdu.dk/da/publications/b6ba4204-b605-499a-a996-7030914bc87f
http://www.journals.elsevier.com/european-journal-of-cancer/
https://doi.org/10.1016/j.ejca.2017.04.025
https://hdl.handle.net/2318/1652484
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85021288157
https://doi.org/10.1016/j.ejca.2017.04.025
https://www.ncbi.nlm.nih.gov/pubmed/28651158

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

Autoren: Yu-Jin Kwon Won Kyu Kim Mi Jang et al.

Weitere Verfasser: Yu-Jin Kwon Won Kyu Kim Mi Jang et al.

Quelle: Oncotarget

Schlagwörter: Male, 0301 basic medicine, Substances, Organoplatinum Compounds, diagnosis, Supplementary concept, Leucovorin, Fluorouracil/adverse effects, Organoplatinum Compounds/therapeutic use, Colorectal Neoplasms/mortality, Antineoplastic Combined Chemotherapy Protocols, Cluster Analysis, Adjuvant, Colorectal, 0303 health sciences, Tumor, Leucovorin/therapeutic use, Colorectal Neoplasms/drug therapy, Middle Aged, Prognosis, Leucovorin/adverse effects, 3. Good health, Treatment Outcome, colon cancer, Chemotherapy, Adjuvant, Female, consensus molecular subtype, Fluorouracil, Colorectal Neoplasms, Research Paper, Adult, mRNA expression-based molecular classification, Fluorouracil/therapeutic use, 03 medical and health sciences, Folfox protocol, Biomarkers, Tumor, Chemotherapy, Humans, Organoplatinum Compounds/adverse effects, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Gene Expression Profiling, DNA microarray, Computational Biology, molecular subtype, Colorectal Neoplasms/genetics, Survival Analysis, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Transcriptome, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/28455965
https://www.europepmc.org/articles/PMC5503619/
https://ir.ymlib.yonsei.ac.kr/bitstream/22282913/160269/1/T201701925.pdf
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160269
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503619
https://www.oncotarget.com/fulltext/17023

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data

Autoren: Jongeneel, Gabrielle Klausch, Thomas van Erning, Felice N. et al.

Weitere Verfasser: Jongeneel, Gabrielle Klausch, Thomas van Erning, Felice N. et al.

Schlagwörter: adjuvant chemotherapy, colon cancer, randomized clinical trial, real-world data, treatment effect, Organoplatinum Compounds/therapeutic use, Humans, Male, Chemotherapy, Adjuvant/methods, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Disease-Free Survival, Fluorouracil/therapeutic use, Netherlands, Female, Neoplasm Staging, Colonic Neoplasms/drug therapy, Leucovorin/therapeutic use, Oncology, Cancer Research, Research Support, Non-U.S. Gov't, Journal Article, Comparative Study

Dateibeschreibung: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/441785

Verfügbarkeit: https://dspace.library.uu.nl/handle/1874/441785

Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms

Autoren: M Heetfeld C N Chougnet I H Olsen et al.

Weitere Verfasser: M Heetfeld C N Chougnet I H Olsen et al.

Quelle: Endocrine-Related Cancer, Vol. 22, no. 4, p. 657-664 (2015)
Heetfeld, M, Chougnet, C N, Olsen, I H, Rinke, A, Borbath, I, Crespo, G, Barriuso, J, Pavel, M, O'Toole, D & Walter, T 2015, 'Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms', Endocrine-related cancer, vol. 22, no. 4, pp. 657-64. https://doi.org/10.1530/ERC-15-0119
Endocrine-Related Cancer

Schlagwörter: Adult, Male, 0301 basic medicine, Organoplatinum Compounds, Leucovorin, Antineoplastic Agents, Fluorouracil/therapeutic use, Young Adult, 03 medical and health sciences, Phytogenic/therapeutic use, 0302 clinical medicine, Organoplatinum Compounds/therapeutic use, Pancreatic Neoplasms/drug therapy, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Antineoplastic Agents, Phytogenic/therapeutic use, Humans, Ki-67 Antigen/metabolism, Aged, Etoposide, Aged, 80 and over, Leucovorin/therapeutic use, Manchester Cancer Research Centre, Etoposide/therapeutic use, Middle Aged, Prognosis, Antineoplastic Agents, Phytogenic, Survival Analysis, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, 3. Good health, Pancreatic Neoplasms, Neuroendocrine Tumors, Ki-67 Antigen, Camptothecin/analogs & derivatives, Neuroendocrine Tumors/drug therapy, Camptothecin, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil

Zugangs-URL: https://erc.bioscientifica.com/downloadpdf/journals/erc/22/4/657.pdf
https://pubmed.ncbi.nlm.nih.gov/26113608
https://dial.uclouvain.be/downloader/downloader.php?pid=boreal:172107&datastream=PDF_01
https://pubmed.ncbi.nlm.nih.gov/26113608/
https://erc.bioscientifica.com/downloadpdf/journals/erc/22/4/657.pdf
https://erc.endocrinology-journals.org/content/22/4/657.long
https://refubium.fu-berlin.de/handle/fub188/8975
https://www.research.manchester.ac.uk/portal/en/publications/characteristics-and-treatment-of-patients-with-g3-gastroenteropancreatic-neuroendocrine-neoplasms(6cbbf00f-e5a0-432a-865a-3d2b2f343fcb).html
https://hdl.handle.net/2078.1/172107

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer

Autoren: Hye Lim Jang Ho Yeong Lim Young Suk Park et al.

Weitere Verfasser: Hye Lim Jang Ho Yeong Lim Young Suk Park et al.

Quelle: Transl Oncol
Translational Oncology, Vol 8, Iss 1, Pp 40-46 (2015)
TRANSLATIONAL ONCOLOGY(8): 1

Schlagwörter: Male, 0301 basic medicine, Deoxycytidine/analogs & derivatives, Cancer Research, Gallbladder Neoplasms/drug therapy, Biliary Tract Neoplasms/epidemiology, Cholangiocarcinoma/pathology, Quinazolines/adverse effects, Biliary Tract Neoplasms/pathology, Disease-Free Survival, Article, Erlotinib Hydrochloride, Quinazolines/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Gallbladder Neoplasms/pathology, Humans, Organoplatinum Compounds/adverse effects, Neoplasm Metastasis, Organoplatinum Compounds/administration & dosage, Deoxycytidine/administration & dosage, RC254-282, Aged, Neoplasm Staging, Deoxycytidine/adverse effects, Gallbladder Neoplasms/epidemiology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cholangiocarcinoma/epidemiology, Middle Aged, Biliary Tract Neoplasms/drug therapy, Organoplatinum Compounds/therapeutic use, Quinazolines/administration & dosage, 3. Good health, Oncology, Cholangiocarcinoma/drug therapy, Disease Progression, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, Deoxycytidine/therapeutic use

Dateibeschreibung: 40~46

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/25749176
https://doaj.org/article/6e68cdfd223a4dd3b92bede36ed829c6
http://open-repository.kisti.re.kr/cube/handle/open_repository/481967.do
https://mdanderson.elsevierpure.com/en/publications/molecular-subgroup-analysis-of-clinical-outcomes-in-a-phase-3-stu
https://ir.ymlib.yonsei.ac.kr/handle/22282913/141497
https://www.sciencedirect.com/science/article/pii/S1936523314001375
https://mdanderson.influuent.utsystem.edu/en/publications/molecular-subgroup-analysis-of-clinical-outcomes-in-a-phase-3-stu
http://europepmc.org/articles/PMC4350637
https://pubmed.ncbi.nlm.nih.gov/25749176/

Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis: Palliative Surgery in Colorectal Cancer

Autoren: Min Sung Kim MinKyu Chung Nam Kyu Kim et al.

Weitere Verfasser: Min Sung Kim MinKyu Chung Nam Kyu Kim et al.

Quelle: Journal of Surgical Oncology. 110:214-221

Schlagwörter: Male, Leucovorin, Kaplan-Meier Estimate, Deoxycytidine, 0302 clinical medicine, Organoplatinum Compounds/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Adjuvant, Colectomy, Leucovorin/therapeutic use, Colorectal Neoplasms/drug therapy, Middle Aged, Antineoplastic Agents/administration & dosage, 3. Good health, Survival Rate, Fluorouracil/analogs & derivatives, Treatment Outcome, Chemotherapy, Adjuvant, Female, Fluorouracil, Colorectal Neoplasms, Rectum/surgery, Camptothecin/analogs & derivatives, Adult, Deoxycytidine/analogs & derivatives, Antineoplastic Agents, Fluorouracil/therapeutic use, Drug Administration Schedule, 03 medical and health sciences, synchronous unresectable metastasis, Chemotherapy, Humans, Camptothecin/therapeutic use, Capecitabine, Retrospective Studies, Aged, Palliative Care/methods, Colorectal Neoplasms/surgery, Colorectal Neoplasms/pathology, Colorectal Neoplasms/mortality, primary tumor resection, Asymptomatic Diseases, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Camptothecin, colorectal neoplasm, Deoxycytidine/therapeutic use, Follow-Up Studies

Dateibeschreibung: 214~221

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/24668581
https://yonsei.pure.elsevier.com/en/publications/clinical-significance-of-primary-tumor-resection-in-colorectal-ca
https://europepmc.org/article/MED/24668581
https://koreauniv.pure.elsevier.com/en/publications/clinical-significance-of-primary-tumor-resection-in-colorectal-ca
https://ir.ymlib.yonsei.ac.kr/handle/22282913/99671
https://onlinelibrary.wiley.com/doi/full/10.1002/jso.23607
https://www.ncbi.nlm.nih.gov/pubmed/24668581

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study

Autoren: Hyun Chul Chung Nam Kyu Kim Se Hyun Kim et al.

Weitere Verfasser: Hyun Chul Chung Nam Kyu Kim Se Hyun Kim et al.

Quelle: Annals of Surgical Oncology. 20:3407-3413

Schlagwörter: Mucinous/genetics, Male, Microsatellite Instability, Organoplatinum Compounds, Mucinous/mortality, Mucinous Adenocarcinoma, Leucovorin, Independent Poor Prognostic Factor, Severance Hospital, 0302 clinical medicine, Colonic Neoplasms/drug therapy, Organoplatinum Compounds/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Aged, 80 and over, Mucinous/pathology, Leucovorin/therapeutic use, Colon Cancer, Colonic Neoplasms/pathology, Colonic Neoplasms/genetics, Middle Aged, Prognosis, Adenocarcinoma, Mucinous, 3. Good health, Survival Rate, Colonic Neoplasms, Female, Fluorouracil, Local/pathology, Adult, Adolescent, Adenocarcinoma, Local/mortality, Fluorouracil/therapeutic use, Local/genetics, Local/drug therapy, Young Adult, 03 medical and health sciences, Mucinous/drug therapy, Humans, Aged, Neoplasm Staging, Retrospective Studies, Lymphovascular Invasion, Colonic Neoplasms/mortality, Neoplasm Recurrence, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Neoplasm Recurrence, Local, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/23943026
https://link.springer.com/article/10.1245/s10434-013-3169-1
https://europepmc.org/abstract/MED/23943026
https://link.springer.com/content/pdf/10.1245%252Fs10434-013-3169-1.pdf
https://pubmed.ncbi.nlm.nih.gov/23943026/
https://mdanderson.elsevierpure.com/en/publications/prognostic-value-of-mucinous-histology-depends-on-microsatellite-
https://snucm.elsevierpure.com/en/publications/prognostic-value-of-mucinous-histology-depends-on-microsatellite-

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Autoren: Gavin, Patrick G Colangelo, Linda H Fumagalli, Debora et al.

Quelle: Clinical Cancer Research. 18:6531-6541

Schlagwörter: Proto-Oncogene Proteins B-raf, Colonic Neoplasms -- drug therapy -- genetics -- mortality -- pathology, Organoplatinum Compounds, Antineoplastic Agents, Prognosis, DNA Mismatch Repair, Sciences biomédicales, 3. Good health, Cancérologie, Oxaliplatin, Treatment Outcome, Mutation Rate, Colonic Neoplasms, Mutation, Antineoplastic Agents -- therapeutic use, Organoplatinum Compounds -- therapeutic use, Humans, Proto-Oncogene Proteins B-raf -- genetics, Microsatellite Instability, Neoplasm Staging

Dateibeschreibung: 1 full-text file(s): application/pdf

Zugangs-URL: https://europepmc.org/articles/pmc4273673?pdf=render
https://pubmed.ncbi.nlm.nih.gov/23045248
http://www.ncbi.nlm.nih.gov/pubmed/23045248/
https://pubmed.ncbi.nlm.nih.gov/23045248/
https://tohoku.pure.elsevier.com/en/publications/mutation-profiling-and-microsatellite-instability-in-stage-ii-and
https://europepmc.org/article/MED/23045248
http://clincancerres.aacrjournals.org/content/clincanres/18/23/6531.full.pdf
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-12-0605

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

Autoren: Lech Chyczewski Marzena Ciechowicz Cezary Szczylik et al.

Quelle: Cancer Biol Ther

Schlagwörter: Adult, Male, Proto-Oncogene Proteins B-raf, Organoplatinum Compounds, Organoplatinum compounds - therapeutic use, Antineoplastic Agents, Camptothecin - therapeutic use, Colorectal neoplasms - genetics, Irinotecan, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, 80 and over, Camptothecin - analogs & derivatives, Predictive value of tests, Humans, Middle aged, ras, Aged, Aged, 80 and over, Colorectal neoplasms - drug therapy, Middle Aged, Prognosis, Antineoplastic agents - therapeutic use, 3. Good health, Oxaliplatin, Genes, ras, Genes, Mutation, Clinical Study, Camptothecin, Female, Colorectal neoplasms - pathology, Colorectal Neoplasms, Proto-oncogene proteins B-raf - genetics

Zugangs-URL: https://www.tandfonline.com/doi/pdf/10.4161/cbt.21813?needAccess=true
https://pubmed.ncbi.nlm.nih.gov/22909976
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493430/
https://www.tandfonline.com/doi/full/10.4161/cbt.21813
https://europepmc.org/abstract/MED/22909976

Integrated epigenomics identifiesBMP4as a modulator of cisplatin sensitivity in gastric cancer

Autoren: Yonghui Wu Minghui Lee Dan Huang et al.

Weitere Verfasser: Yonghui Wu Minghui Lee Dan Huang et al.

Quelle: Gut. 62:22-33

Schlagwörter: Epigenomics, 0301 basic medicine, Organoplatinum Compounds, Drug Resistance, Antineoplastic Agents, Bone Morphogenetic Protein 4, Adenocarcinoma, Stomach Neoplasms/metabolism, Cell Line, Cisplatin/pharmacology, Antineoplastic Agents/pharmacology, Neoplastic/drug effects, 03 medical and health sciences, Stomach Neoplasms/mortality, Adenocarcinoma/genetics, Adenocarcinoma/drug therapy, Organoplatinum Compounds/therapeutic use, Stomach Neoplasms, Bone Morphogenetic Protein 4/genetics, Cell Line, Tumor, Tumor/metabolism, Biomarkers, Tumor, Humans, Gene Silencing, Tumor, Gene Expression Profiling, Antineoplastic Agents/therapeutic use, Epigenomics/methods, DNA Methylation, DNA Methylation/drug effects, Prognosis, Tumor/genetics, 3. Good health, Gene Expression Regulation, Neoplastic, Oxaliplatin, Stomach Neoplasms/genetics, Gene Expression Regulation, Adenocarcinoma/metabolism, Drug Resistance, Neoplasm, Adenocarcinoma/mortality, Bone Morphogenetic Protein 4/metabolism, Neoplasm/genetics, Organoplatinum Compounds/pharmacology, Stomach Neoplasms/drug therapy, Cisplatin/therapeutic use, Cisplatin, Biomarkers

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/22535375
https://mdanderson.elsevierpure.com/en/publications/integrated-epigenomics-identifies-bmp4-as-a-modulator-of-cisplati
https://europepmc.org/abstract/MED/22535375
https://yonsei.pure.elsevier.com/en/publications/integrated-epigenomics-identifies-bmp4-as-a-modulator-of-cisplati
https://gut.bmj.com/content/62/1/22
https://gut.bmj.com/content/gutjnl/62/1/22.full.pdf
https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2011-301113

Economic and patient-reported outcomes of outpatient home-based versus inpatient hospital-based chemotherapy for patients with colorectal cancer

Autoren: Hye Young Kang Eun Hye Joo Joong Bae Ahn et al.

Weitere Verfasser: Hye Young Kang Eun Hye Joo Joong Bae Ahn et al.

Quelle: Supportive Care in Cancer. 19:971-978

Schlagwörter: Male, Leucovorin/economics, Organoplatinum Compounds/economics, Self Report/economics, Organoplatinum Compounds, Cost-Benefit Analysis, Statistics as Topic, Leucovorin, Fluorouracil/economics, Inpatients/statistics & numerical data, 0302 clinical medicine, Organoplatinum Compounds/therapeutic use, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Outpatients, Home infusion therapy, Outcome, Leucovorin/therapeutic use, Colorectal Neoplasms/drug therapy, Patient satisfaction, Focus Groups, Middle Aged, Home Care Services, 3. Good health, Patient Satisfaction, Regression Analysis, Female, Fluorouracil, Colorectal Neoplasms, Outpatients/statistics & numerical data, Home Care Services/economics, Cost, Antineoplastic Agents, Fluorouracil/therapeutic use, 03 medical and health sciences, Republic of Korea, Chemotherapy, Humans, Aged, Inpatients, Antineoplastic Agents/therapeutic use, Colorectal cancer, Health Surveys, Colorectal Neoplasms/economics, Patient Satisfaction/statistics & numerical data, Home Care Services/statistics & numerical data, Multivariate Analysis, Antineoplastic Agents/economics, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/economics

Dateibeschreibung: 971~978

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/20496154
http://europepmc.org/abstract/MED/20496154
https://yonsei.pure.elsevier.com/en/publications/economic-and-patient-reported-outcomes-of-outpatient-home-based-v
https://link.springer.com/content/pdf/10.1007%2Fs00520-010-0917-7.pdf
https://mdanderson.elsevierpure.com/en/publications/economic-and-patient-reported-outcomes-of-outpatient-home-based-v
https://www.ncbi.nlm.nih.gov/pubmed/20496154
https://link.springer.com/article/10.1007/s00520-010-0917-7

Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin’s lymphoma: a consortium for improving survival of lymphoma (CISL) trial

Autoren: Byeong Bae Park Dae Ho Lee Young Yiul Lee et al.

Weitere Verfasser: Byeong Bae Park Dae Ho Lee Young Yiul Lee et al.

Quelle: Investigational New Drugs. 29:154-160

Schlagwörter: Dexamethasone/administration & dosage, Adult, Male, Deoxycytidine/analogs & derivatives, Lymphoma, Organoplatinum Compounds, Salvage therapy, Antineoplastic Agents, Ifosfamide/therapeutic use, Salvage Therapy, Deoxycytidine, Dexamethasone, Disease-Free Survival, Dexamethasone/therapeutic use, Non-Hodgkin/pathology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Organoplatinum Compounds/adverse effects, Ifosfamide, Organoplatinum Compounds/administration & dosage, Deoxycytidine/administration & dosage, Aged, B-Lymphocytes, Deoxycytidine/adverse effects, Dexamethasone/adverse effects, Lymphoma, Non-Hodgkin, Antineoplastic Agents/therapeutic use, Antineoplastic Agents/adverse effects, Non-Hodgkin/drug therapy, Ifosfamide/adverse effects, Middle Aged, Organoplatinum Compounds/therapeutic use, Ifosfamide/administration & dosage, Gemcitabine, Antineoplastic Agents/administration & dosage, 3. Good health, B-Lymphocytes/pathology, Oxaliplatin, Treatment Outcome, Non-Hodgkin's lymphoma, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Deoxycytidine/therapeutic use

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/19756371
https://link.springer.com/content/pdf/10.1007%2Fs10637-009-9320-y.pdf
https://link.springer.com/article/10.1007/s10637-009-9320-y/fulltext.html
https://mdanderson.elsevierpure.com/en/publications/salvage-therapy-with-gemcitabine-ifosfamide-dexamethasone-and-oxa
http://www.ncbi.nlm.nih.gov/pubmed/19756371
https://pubmed.ncbi.nlm.nih.gov/19756371/
https://link.springer.com/article/10.1007/s10637-009-9320-y

Photon activation therapy and brachytherapy

Autoren: Laster, B. H. Dixon, D. W. Novick, S. et al.

Quelle: Brachytherapy. 8:324-330

Schlagwörter: Radioisotopes, Mice, Inbred BALB C, Photons, Organoplatinum Compounds, Metalloporphyrins, Brachytherapy, Metalloporphyrins/therapeutic use, Intercalating Agents/therapeutic use, Mammary Neoplasms, Experimental, Brachytherapy/*methods, DNA, Neoplasm, Intercalating Agents, 3. Good health, DNA, Neoplasm/metabolism, Mice, 03 medical and health sciences, Mammary Neoplasms, Experimental/*radiotherapy, 0302 clinical medicine, Organoplatinum Compounds/therapeutic use, Animals, Female, Palladium

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/19428312
https://europepmc.org/article/MED/19428312
https://www.sciencedirect.com/science/article/pii/S1538472109001962
http://olympias.lib.uoi.gr/jspui/handle/123456789/19295